652 filings
Page 22 of 33
8-K
aqjt98
6 Oct 09
Regulation FD Disclosure
12:00am
8-K
awc3oirv2
14 Aug 09
OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
12:00am
8-K
qw4kh j0jso11nnh8w
6 Aug 09
Results of Operations and Financial Condition
12:00am
8-K
8ac57 h5o7g50
24 Jul 09
OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
12:00am
424B5
mn4vxt87ifr fn
20 Jul 09
Prospectus supplement for primary offering
12:00am
8-K
zw8czw6
20 Jul 09
Entry into a Material Definitive Agreement
12:00am
EFFECT
hwxcf3uysibiy
17 Jul 09
Notice of effectiveness
12:00am
CORRESP
fb3chq zhi
15 Jul 09
Correspondence with SEC
12:00am
CORRESP
vu58b 1i8oko
13 Jul 09
Correspondence with SEC
12:00am
UPLOAD
hbc4p
9 Jul 09
Letter from SEC
12:00am
CORRESP
vnlo6ooc
26 Jun 09
Correspondence with SEC
12:00am
8-K
csgac0apx1 89pty1hch
26 Jun 09
OncoGenex Pharmaceuticals Files Shelf Registration Statement
12:00am
8-K
t0pkiu
24 Jun 09
Regulation FD Disclosure
12:00am
8-K
oktqzrf1amo9fd i5u5m
3 Jun 09
OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
12:00am
8-K
2n4 pdh073nk
18 May 09
Regulation FD Disclosure
12:00am
8-K
i8l30ni49g0dzqziipv
7 May 09
Results of Operations and Financial Condition
12:00am